Dr. Stockwell has over 12 years research experience focusing primarily on investigating potential anti-dyskinesiogenic and neuroprotective therapies in in vivo and in vitro models of Parkinson’s disease. She obtained her PhD from King’s College London working with Professor Peter Jenner at the Neurodegenerative Diseases Research Centre before joining Proximagen when it was founded – a spin-out company from Peter Jenner’s group.